- Home
- CSBR vs PFD Comparison
CSBR vs PFD Comparison
Compare CSBR & PFD Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- CSBR
- PFD
- Stock Information
- Founded
- CSBR 1985
- PFD 1990
- Country
- CSBR United States
- PFD United States
- Employees
- CSBR N/A
- PFD N/A
- Industry
- CSBR Biotechnology: Biological Products (No Diagnostic Substances)
- PFD Investment Managers
- Sector
- CSBR Health Care
- PFD Finance
- Exchange
- CSBR Nasdaq
- PFD Nasdaq
- Market Cap
- CSBR 135.5M
- PFD 144.5M
- IPO Year
- CSBR 1986
- PFD N/A
- Fundamental
- Price
- CSBR $8.78
- PFD $11.21
- Analyst Decision
- CSBR Strong Buy
- PFD
- Analyst Count
- CSBR 1
- PFD 0
- Target Price
- CSBR $12.00
- PFD N/A
- AVG Volume (30 Days)
- CSBR 42.6K
- PFD 33.2K
- Earning Date
- CSBR 03-11-2025
- PFD 01-01-0001
- Dividend Yield
- CSBR N/A
- PFD 6.30%
- EPS Growth
- CSBR N/A
- PFD N/A
- EPS
- CSBR 0.46
- PFD N/A
- Revenue
- CSBR $58,591,000.00
- PFD N/A
- Revenue This Year
- CSBR $14.19
- PFD N/A
- Revenue Next Year
- CSBR $10.11
- PFD N/A
- P/E Ratio
- CSBR $19.92
- PFD N/A
- Revenue Growth
- CSBR 19.03
- PFD N/A
- 52 Week Low
- CSBR $3.60
- PFD $8.53
- 52 Week High
- CSBR $11.99
- PFD $11.18
- Technical
- Relative Strength Index (RSI)
- CSBR 41.24
- PFD 45.97
- Support Level
- CSBR $9.21
- PFD $11.14
- Resistance Level
- CSBR $9.97
- PFD $11.35
- Average True Range (ATR)
- CSBR 0.67
- PFD 0.09
- MACD
- CSBR -0.07
- PFD -0.00
- Stochastic Oscillator
- CSBR 13.66
- PFD 37.50
About CSBR Champions Oncology Inc.
Champions Oncology Inc is a USA based company which is engaged in the development and sale of state of the art technology solutions and products to personalize the development and use of oncology drugs. The company operates through one segment namely Personalized Oncology Solutions (POS) and Translational Oncology Solutions (TOS). Its POS business assists physicians in developing personalized treatment options for their cancer patients through tumor-specific data obtained from drug panels and related personalized oncology services. The TOS business assists pharmaceutical and biotechnology companies with their drug development process and offers studies or license tumors for use in studies. The company's revenue is majorly derived from research services.
About PFD Flaherty & Crumrine Preferred and Income Fund Incorporated
Flaherty & Crumrine Prefd Inc Fund Inc is a United States-based diversified, closed-end management investment company. Its investment objective is to provide its common shareholders with high current income consistent with the preservation of capital. The fund invests in a diversified portfolio of preferred securities, which includes traditional preferred stocks eligible for the inter-corporate dividends received a deduction and fully taxable preferred securities.